Marella Thorell - May 27, 2021 Form 3 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Accounting Officer
Signature
/s/ Marella Thorell
Stock symbol
CNTA
Transactions as of
May 27, 2021
Transactions value $
$0
Form type
3
Date filed
5/27/2021, 08:25 PM
Next filing
Jun 4, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CNTA Share Option (right to buy) May 27, 2021 Ordinary Shares 59K $4.11 Direct F1, F2, F3
holding CNTA Share Option (right to buy) May 27, 2021 Ordinary Shares 9.49K $4.87 Direct F2, F3, F4
holding CNTA Share Option (right to buy) May 27, 2021 Ordinary Shares 208K $5.84 Direct F2, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 56.25% of the shares subject to such option are vested as of January 29, 2021. The remaining 43.75% of the shares subject to such option shall vest and become exercisable monthly beginning on February 1, 2021.
F2 Represents A Ordinary Shares that will be redesignated as Ordinary Shares immediately prior to the closing of the initial public offering.
F3 Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F4 25% of the shares subject to such option are vested as of January 29, 2021. The remaining 75% of the shares subject to such option shall vest and become exercisable monthly beginning on February 1, 2021.
F5 25% of the shares subject to such option shall vest and become exercisable on February 19, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.

Remarks:

Exhibit 24 - Power of Attorney